Ishophloroglucin A Isolated From Ishige okamurae Stimulates Osteoblast Differentiation Through Activation of the Bone Morphogenetic Protein and Wnt/β‐Catenin Signaling Pathways in MC3T3‐E1 Cells
Cell Biology International · 2025
DOI: 10.1002/cbin.70030 ↗At a glance
Journal article in Cell Biology International, 2025. Written by Seung-Hong Lee and 4 co-authors. Institution: Department of Pharmaceutical Engineering, Soonchunhyang University, Asan, Republic of Korea. Major MEDLINE topics: Osteoblasts, Cell Differentiation, Wnt Signaling Pathway, Phaeophyceae. Cited 1 times so far (Crossref); 48 references. Funded by: This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2020R1C1C1006299). This study was….
Abstract (original language)
Current osteoporosis treatments are insufficient as they cause a relatively small increase in bone mass and are unable to recover lost bone structures, in addition to having severe side effects. The bone morphogenetic protein (BMP) and Wnt/β‐catenin signaling pathways cooperatively modulate bone formation and osteoblast differentiation and therefore may play a role in treating osteoporosis. This study aimed to investigate the effects of Ishophloroglucin A (IPA), a novel phenolic compound isolated from Ishige okamurae , on osteoblast differentiation by activating the BMP and Wnt/β‐catenin signaling pathways. According to our findings, IPA significantly promoted the osteogenic proliferation of MC3T3‐E1 osteoblastic cells and increased alkaline phosphatase (ALP) activity and calcium nodule formation in MC3T3‐E1 cells compared to the untreated control. IPA also upregulated osteogenesis markers such as type 1 collagen, ALP, p‐Smad1/5/8, osterix, osteopontin, runt‐related transcription factors (Runx2), and BMP2 in MC3T3‐E1 cells in a dose‐dependent manner. Moreover, IPA activated Wnt3a, LRP5, DVL2, and β‐catenin in MC3T3‐E1 cells. Overall, our results demonstrate that IPA promotes the differentiation of MC3T3‐E1 osteoblastic cells by activating the BMP and Wnt/β‐catenin signaling pathways, suggesting that it may be a potential candidate target for treating or preventing osteoporosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Engineering, Soonchunhyang University, Asan, Republic of Korea.
- Department of Food and Nutrition, College of Medical and Life Science, Silla University, Busan, Republic of Korea.
- Department of Bioscience and Research Center for Extremophiles and Marine Microbiology, Silla University, Busan, Republic of Korea.
ORCID profiles: Mi Hwa Park
Funding
- This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2020R1C1C1006299). This study was…
Cite
APA
Lee, S. H., Kim, M., Jung, K. I., Lee, S. J., & Park, M. H. (2025). Ishophloroglucin A Isolated From Ishige okamurae Stimulates Osteoblast Differentiation Through Activation of the Bone Morphogenetic Protein and Wnt/β‐Catenin Signaling Pathways in MC3T3‐E1 Cells. Cell Biology International. https://doi.org/10.1002/cbin.70030
Vancouver
Lee SH, Kim M, Jung KI, Lee SJ, Park MH. Ishophloroglucin A Isolated From Ishige okamurae Stimulates Osteoblast Differentiation Through Activation of the Bone Morphogenetic Protein and Wnt/β‐Catenin Signaling Pathways in MC3T3‐E1 Cells. Cell Biology International. 2025. doi:10.1002/cbin.70030
BibTeX
@article{Lee2025,
author = {Lee, Seung-Hong and Kim, Mihyang and Jung, Kyung Im and Lee, Sang-Jae and Park, Mi Hwa},
title = {Ishophloroglucin A Isolated From Ishige okamurae Stimulates Osteoblast Differentiation Through Activation of the Bone Morphogenetic Protein and Wnt/β‐Catenin Signaling Pathways in MC3T3‐E1 Cells},
journal = {Cell Biology International},
year = {2025},
doi = {10.1002/cbin.70030}
}
EUVIMED